Actively Recruiting
Evaluating Everolimus Treatment for Kidney Transplant Patients with NK Cell-Mediated Missing Self Rejection
Led by Hospices Civils de Lyon · Updated on 2026-10-22
20
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the effectiveness of the drug Everolimus in treating kidney transplant patients who experience a specific type of rejection involving natural killer NK cells. This rejection is linked to the absence of self Major Histocompatibility Complex MHC class I molecules on the transplanted kidneys cells, which triggers NK cell activity. The study focuses on patients with this missing self condition causing NK-mediated rejection, exploring a treatment approach that combines Everolimus with other immunosuppressive drugs. During the study, 20 kidney transplant patients with this NK-mediated rejection will receive Everolimus orally for six months at doses adjusted to maintain specific drug levels. Everolimus will replace their previous anti-proliferative medication and will be given alongside corticosteroids and a calcineurin inhibitor. Researchers will monitor kidney function, biopsy results, and NK cell activation throughout the treatment period to assess changes related to the therapy. Participants will be followed for six months after starting Everolimus treatment. They will undergo regular assessments including kidney function tests, kidney biopsy to check rejection lesions, measurements of NK cell activity, and proteinuria levels. These evaluations will help determine the impact of Everolimus on graft health and immune response. The studys primary outcome is the change in estimated glomerular filtration rate after six months, with additional measures focusing on rejection severity and immune cell behavior.
CONDITIONS
Brief Title
Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection
Research Team
A
Alice KOENIG, MD
D
Daniel SPERANDIO, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here